ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,476 Cr | ₹5,902 Cr | ₹5,178 Cr | ₹4,539 Cr | ₹4,207 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹6,476 Cr |
| Mar2025 | ₹5,902 Cr |
| Mar2024 | ₹5,178 Cr |
| Mar2023 | ₹4,539 Cr |
| Mar2022 | ₹4,207 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,476 Cr | 9.72 | |
| Mar2025 | ₹5,902 Cr | 14.00 | |
| Mar2024 | ₹5,178 Cr | 14.08 | |
| Mar2023 | ₹4,539 Cr | 7.88 | |
| Mar2022 | ₹4,207 Cr | - | |
Compare Total Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,103.9 Cr | -1.3% | 1.8% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -1.3% |
1.8% |
-12.9% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses